Clinical Trial Update: Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of a fixed-dose combination of glimepiride and metformin in patients with inadequately controlled type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• metformin (metformin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED